Shares of Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS – Get Free Report) have earned an average rating of “Moderate Buy” from the six research firms that are currently covering the stock, Marketbeat reports. One analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and four have given a buy recommendation to the company. The average 1 year price objective among analysts that have issued ratings on the stock in the last year is $17.20.
A number of equities research analysts have recently weighed in on the company. Mizuho dropped their price target on Senseonics Holdings, Inc. Common Stock from $20.00 to $18.00 and set an “outperform” rating on the stock in a research note on Wednesday. Stifel Nicolaus lowered their target price on shares of Senseonics Holdings, Inc. Common Stock from $9.00 to $8.00 and set a “hold” rating for the company in a research note on Monday, May 11th. HC Wainwright lowered their target price on shares of Senseonics Holdings, Inc. Common Stock from $18.50 to $14.00 and set a “buy” rating for the company in a research note on Tuesday, May 12th. Finally, Weiss Ratings downgraded shares of Senseonics Holdings, Inc. Common Stock from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Thursday, May 28th.
Get Our Latest Stock Analysis on Senseonics Holdings, Inc. Common Stock
Insider Activity at Senseonics Holdings, Inc. Common Stock
Hedge Funds Weigh In On Senseonics Holdings, Inc. Common Stock
Several hedge funds have recently made changes to their positions in SENS. Bank of America Corp DE raised its stake in Senseonics Holdings, Inc. Common Stock by 126.8% in the 1st quarter. Bank of America Corp DE now owns 56,964 shares of the company’s stock worth $379,000 after acquiring an additional 31,849 shares during the last quarter. Masters Capital Management LLC grew its stake in Senseonics Holdings, Inc. Common Stock by 100.0% during the 1st quarter. Masters Capital Management LLC now owns 500,000 shares of the company’s stock valued at $3,330,000 after purchasing an additional 250,002 shares during the last quarter. Cetera Investment Advisers acquired a new position in shares of Senseonics Holdings, Inc. Common Stock in the first quarter valued at about $85,000. Kestra Advisory Services LLC acquired a new position in shares of Senseonics Holdings, Inc. Common Stock in the first quarter valued at about $68,000. Finally, Aristides Capital LLC purchased a new position in shares of Senseonics Holdings, Inc. Common Stock in the fourth quarter worth about $139,000. 12.36% of the stock is owned by institutional investors and hedge funds.
Senseonics Holdings, Inc. Common Stock Price Performance
Shares of SENS stock opened at $5.11 on Friday. Senseonics Holdings, Inc. Common Stock has a 1-year low of $4.79 and a 1-year high of $12.51. The stock’s fifty day simple moving average is $6.11. The company has a current ratio of 3.51, a quick ratio of 3.19 and a debt-to-equity ratio of 1.05. The stock has a market cap of $213.60 million, a P/E ratio of -2.56 and a beta of 0.99.
Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS – Get Free Report) last released its quarterly earnings results on Thursday, May 7th. The company reported ($0.71) EPS for the quarter, missing analysts’ consensus estimates of ($0.65) by ($0.06). Senseonics Holdings, Inc. Common Stock had a negative net margin of 213.87% and a negative return on equity of 129.97%. The business had revenue of $11.71 million during the quarter. As a group, equities research analysts anticipate that Senseonics Holdings, Inc. Common Stock will post -2.38 earnings per share for the current year.
Senseonics Holdings, Inc. Common Stock Company Profile
Senseonics Holdings, Inc develops and commercializes long-term implantable continuous glucose monitoring (CGM) systems for people with diabetes. The company’s primary product family is the Eversense system, which combines a small subcutaneously implanted sensor, a removable external transmitter, and companion smartphone applications to provide continuous glucose readings and alerts. Senseonics positions its technology as an alternative to wearable patch-style CGMs by offering multi-month sensor longevity and on-body vibration alerts delivered through the transmitter.
Senseonics supports clinical and commercial activities that include research and development, regulatory engagement, manufacturing and distribution, and training for healthcare providers who perform sensor insertion and removal.
Featured Articles
- Five stocks we like better than Senseonics Holdings, Inc. Common Stock
- AST SpaceMobile Stock Sinks as SpaceX Fallout Rattles Space Sector
- Aehr Test Systems Stock Soars on Earnings, Eyes Over 150% Revenue Growth
- TSMC Just Gave AI Chip Bulls Another Reason to Stay Confident
- GE Aerospace Faces a Prove-It Moment in Q2 Earnings
Receive News & Ratings for Senseonics Holdings Inc. Common Stock Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senseonics Holdings Inc. Common Stock and related companies with MarketBeat.com's FREE daily email newsletter.
